期刊文献+

雌激素与脱氢表雄酮改善去势雌兔动脉粥样硬化的对比研究 被引量:5

Comparision of the effects between estrogen and dehydroepiandrosterone on improving atherosclerosis of ovariectomized rabbits
下载PDF
导出
摘要 目的:比较雌激素与普拉睾酮(脱氢表雄酮,DHEA)对卵巢切除(OVX)的去势雌兔动脉粥样硬化形成的影响。方法:将30只3月龄新西兰雌兔随机分为五组,即正常对照组、假手术+高脂饮食组、OVX+高脂饮食组、OVX+高脂饮食+苯甲酸雌二醇(E2)组和OVX+高脂饮食+DHEA组。喂养12周末采血,分别测定血脂以及血清一氧化氮(NO)、E2水平;取主动脉及子宫行组织形态学观察以及在光镜和扫描电镜下行病理学检查,利用图像分析仪计算动脉粥样硬化斑块内膜面积比和内膜中膜厚度比、面积比。结果:①12周末对照组兔血清总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)与其他各组相比均有显著性统计学意义(P<0.05),而对照组外的各组间差异均无统计学意义。②OVX+高脂饮食+苯甲酸E2组与OVX+高脂饮食组相比三酰甘油(TG)差异显著(P<0.05)。③OVX+高脂饮食+苯甲酸E2组与OVX+高脂饮食+DHEA组的血清NO水平与OVX+高脂饮食组相比差异非常显著(P<0.01)。④OVX+高脂饮食+苯甲酸E2组和OVX+高脂饮食+DHEA组的血清E2水平与OVX+高脂饮食组相比差异亦非常显著(P<0.01)。⑤OVX+高脂饮食+苯甲酸E2组和OVX+高脂饮食+DHEA组的主动脉硬化斑块面积与动脉内膜比值,内膜中膜厚度比、面积比显著低于OVX+高脂饮食组(P(0.01)。⑥OVX+高脂饮食+苯甲酸E2组子宫内膜增生明显,而OVX+高脂饮食+DHEA组无此现象。结论:雌激素和DHEA均可减轻动脉粥样硬化早期的病理改变,可预防和减少动脉粥样硬化的形成。 Objective:To compare the effects between estrogen and Prasterone (Dehydroepiandrosterone, DHEA) on improving atherosclerosis of ovariectomized rabbits. Methods: Thirty female New Zealand white rabbits of three months old were randomly divided into five groups: Group A: normal control; Group B: sham operation + high cholesterol feeding; Group C: ovariectomized + high cholesterol feeding; Group D: ovariectomized + high cholesterol feeding + estradiol benzoate; Group E: ovariectomized + high cholesterol feeding + DHEA. Twelve weeks later, all rabbits were sacrificed, the serum TC, TG, LDL-C, HDL-C, NO and estradiol levels were measured. The aortas and uterus were harvested for histomorphometrical evaluation with light and scanning electron microscope. The area ratios of atherosclerotic lesion to endothelium, and the thickness and area ratios of endothelium to the medium were determined by computer. Results: ①Following the treatment for 12 weeks, no significant difference was found in serum TC,LDL-C,HDL-C levels among four groups except in group A. ②There were significant differences between the serum triglyceride (TC)levels of group D and group C. ③The serum No levels of group D and group E were significantly higher than that of groupC. ④The serum estradiol levels of group D and group E were significantly higher than that of groupC. ⑤The area ratios of atherosclerotic lesion to endothelium and the thickness and area ratios of endothelium to the medium in group D and group E were significantly lower than that of group C. ⑥Endometrial hyperplasia of group D was significant, while there was no such Phenomena in group E. Conclusion: Estrogen and DHEA can alleviate the early pathological changes of atherosclerosis of the ovariectomized rabbits, prevent and reduce the formation of atherosclerosis.
出处 《医学研究生学报》 CAS 2007年第5期481-485,I0004,共6页 Journal of Medical Postgraduates
基金 国家自然科学基金资助项目(批准号:30400353)
关键词 动脉粥样硬化 去势 雌二醇 普拉睾酮 Atherosclerosis Ovariectomy Estrogen Prasterone
  • 相关文献

参考文献10

  • 1Nathan L,Chaudhuri G.Estrogens and atherosclerosis[J].Annu Rev Pharmacol Toxicol,1997,37 (4):477-515.
  • 2Morales AJ,Nolan JJ,Nelson JC,et al.Effects of replacement dose of dehydroepiandrosterone in men andwomen of advancing age[J].J Clin Endocrinol Metab,1994;78(6):1360-1367.
  • 3王凤斌,唐可欣,姜红心,管英俊,王亚南.雌二醇对去卵巢大鼠延髓毛细血管超微结构的影响[J].医学研究生学报,2005,18(1):27-29. 被引量:2
  • 4Schnatz PF.Hormonal therapy:does it increase or decrease cardiovascular risk?[J] Obstet Gynecol Surv,2006,61 (10):673-681.
  • 5Boyle EM,Lille ST,Allaire E,et al.Endothelial cell injury in cardiovascular surgery:atherosclerosis[J].Ann Thorac Surg,1997,63(3):885-894.
  • 6Gurnell EM,Chatterjee VK.Dehydroepiandrosterone replacement therapy[J].Eur J Endocrinol,2001,145(2):103-106.
  • 7张德太,胡丽华,杨渝珍.脱氢表雄酮对体外培养Burkit淋巴瘤细胞抗氧化能力影响的研究[J].医学研究生学报,2005,18(9):776-778. 被引量:7
  • 8Lamberts SW,van den Belod AW,van der Lely AJ.The endocrinology of aging[J].Science,1997,278 (17) 419-424.
  • 9Tode T,Kikuchi Y,Hirata J,et al.Effect of Korean red ginseng on psychological functions in patients with severe climacteric syndromes[J].Int J Gynaecol Obstet,1999,67(3):169-174.
  • 10庄祥云.骨质疏松症的药物治疗──脱氢表雄酮(DHEA)[J].日本医学介绍,1996,17(2):68-69. 被引量:4

二级参考文献19

  • 1张德太,姜伟超,杨渝珍.葡萄糖-6-磷酸脱氢酶缺乏对中性粒细胞的影响[J].医学研究生学报,2005,18(2):112-114. 被引量:1
  • 2Windler E.Modification of serum lipids and cardiovascular risk by estrogenic active compounds[J]. Gynecol Endocrinol,1999,13(6):21-28.
  • 3Nanda S, Gupta N, Mehta HC et al. Effect of oestrogen replacement therapy on serum lipid profile[J]. Aust NZJ Obstet Gynaecol, 2003 ,43(3):213-216.
  • 4Imperato F, Marziani R, Perniola G et al . Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women [J].Minerva Ginecol, 2003 ,55(1):87-93.
  • 5Stirone C, Chu Y, Sunday L et al. 17beta-estradiol increases endothelial nitric oxide synthase mRNA copy number in cerebral blood vessels: quantification by real-time polymerase chain reaction[J]. Eur J Pharmacol, 2003 ,478(1):35-38.
  • 6Ebeling P, Koivisto V. Physiological importance dehydroepiandrosterone [ J ]. Lancet, 1994,343 ( 12 ): 1479-1481.
  • 7Yang S, Fu ZD, Wang F, et al. Anti-mutagenicity activity of dehydroepiandrosterone[ J]. Chin J Oncol, 2002,24 ( 2 ): 137-140.
  • 8Melvin WS, Boros LG, Muscarella P,etal. Dehydroepiandrosterone-sulfate inhibits pancreatic carcinoma cell proliferation in vitro and in vivo[ J]. Surgery, 1997,121 (4) :392-397.
  • 9Vartanyan LS, Gurevich SM, Kozachenko AI,et al. Imbalance in the enzymatic system of production and consumption of active oxygen species in liver of AKR mice with spontaneous leucosis [ J ].Biochemistry, 2001,66(7) :725-732.
  • 10Lusini L, Tripodi SA, Rossi R,et al. Altered glutathione anti-oxidant metabolism during tumor progression in human renal-cell carcinoma[J]. Int J Cancer,2001,91 ( 1 ) :55-59.

共引文献10

同被引文献96

  • 1赵京林,杨跃进.腺苷与心脏保护的研究进展[J].中国心血管病研究,2004,2(8):658-661. 被引量:11
  • 2王凤斌,唐可欣,姜红心,管英俊,王亚南.雌二醇对去卵巢大鼠延髓毛细血管超微结构的影响[J].医学研究生学报,2005,18(1):27-29. 被引量:2
  • 3班振英,程恒辉,周颖,胡晓静,瞿智玲,阮秋蓉.脱氢表雄酮通过抑制血管细胞粘附分子1的表达发挥抗动脉粥样硬化作用[J].中国动脉硬化杂志,2006,14(10):835-840. 被引量:4
  • 4Webb AL, McCullough ML. Dietary lignans: potential role in cancer prevention [ J ]. Nutr Cancer, 2005, 51 ( 2 ) : 117-131.
  • 5Limer JL, Speirs V. Phyto-oestrogens and breast cancer chemoprevention [ J ]. Breast Cancer Res, 2004, 6 ( 3 ) : 119-127.
  • 6de Lemos ML. Effects of soy phytoestrogens genistein and daidzein on breast cancer growth[ J]. Ann Pharmacother, 2001, 35 (9) :1118-1121.
  • 7Magee PJ, Rowland IR. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer [J]. BrJNutr, 2004, 91(4):513-531.
  • 8Kousidou O, Tzanakakis GN, Karamanos NK. Effects of the natural isoflavonoid genistein on growth, signaling pathways and gene expression of matrix macromolecules by breast cancer cells [J]. Mini Rev Med Chem, 2006, 6(3) :331-337.
  • 9Ahlborg HG, Johnell O, Karlsson MK. Long term effects of oestrogen therapy on bone loss in postmenopausal women : a 23 year prospective study [ J ]. B JOG, 2004, 111 (4) :335-339.
  • 10Ma DF, Qin LQ, Wang PY, et al. Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials[ J]. Clin Nutr, 2008, 27( 1 ) :57-64.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部